DS INPHARMATICS Trademark

Trademark Overview


On Monday, August 5, 2019, a trademark application was filed for DS INPHARMATICS with the United States Patent and Trademark Office. The USPTO has given the DS INPHARMATICS trademark a serial number of 88567150. The federal status of this trademark filing is REGISTERED as of Tuesday, October 6, 2020. This trademark is owned by Design Space InPharmatics LLC. The DS INPHARMATICS trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; consulting services in the field of commercial administration of the licensing of pharmaceutical products of others

Regulatory compliance consulting in the fields of pharmaceutical development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services in the field of pharmaceutical licensing requirements

Providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; technological due diligence consulting in the field of pharmaceutical technology
ds inpharmatics

General Information


Serial Number88567150
Word MarkDS INPHARMATICS
Filing DateMonday, August 5, 2019
Status700 - REGISTERED
Status DateTuesday, October 6, 2020
Registration Number6170784
Registration DateTuesday, October 6, 2020
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements


Description of MarkThe mark consists of three stacked rectangles with one rectangle having a rounded corner and to the right of the rectangles are the letters "DS" and on the bottom of the mark is the word "INPHARMATICS".
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesRegulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; consulting services in the field of commercial administration of the licensing of pharmaceutical products of others
Goods and ServicesRegulatory compliance consulting in the fields of pharmaceutical development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services in the field of pharmaceutical licensing requirements
Goods and ServicesProviding scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; technological due diligence consulting in the field of pharmaceutical technology

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, March 14, 2020
Primary Code035
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateTuesday, January 1, 2019

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 22, 2019
Primary Code042
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateTuesday, January 1, 2019

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 22, 2019
Primary Code045
First Use Anywhere DateTuesday, January 1, 2019
First Use In Commerce DateTuesday, January 1, 2019

Trademark Owner History


Party NameDesign Space InPharmatics LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressGreen Lane, PA 18054

Party NameDesign Space InPharmatics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGreen Lane, PA 18054

Party NameDesign Space InPharmatics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGreen Lane, PA 18054

Trademark Events


Event DateEvent Description
Friday, March 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 8, 2019NEW APPLICATION ENTERED
Thursday, August 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 23, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, October 5, 2019ASSIGNED TO EXAMINER
Wednesday, October 9, 2019NON-FINAL ACTION WRITTEN
Wednesday, October 9, 2019NON-FINAL ACTION E-MAILED
Wednesday, October 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 13, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, March 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2020ASSIGNED TO LIE
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, July 30, 2020USE AMENDMENT FILED
Thursday, July 30, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, August 12, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 3, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 4, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 6, 2020REGISTERED-PRINCIPAL REGISTER
Monday, October 6, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 27, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 13, 2020USE AFFIDAVIT FAILED FORMALITIES
Tuesday, August 25, 2020RESPONSE TO ITU OFFICE ACTION ENTERED
Tuesday, August 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED